4//SEC Filing
Aurentz Vincent 4
Accession 0000950170-25-093436
CIK 0001750149other
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 7:49 PM ET
Size
22.2 KB
Accession
0000950170-25-093436
Insider Transaction Report
Form 4
Aurentz Vincent
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-30+108,176→ 108,176 totalExercise: $1.95Exp: 2032-06-30→ Common Stock (108,176 underlying)
Footnotes (1)
- [F1]The options will vest on the earlier of June 30, 2026 or the day prior to the next annual meeting of stockholders, subject to the director's continued service through such date.
Documents
Issuer
Inhibikase Therapeutics, Inc.
CIK 0001750149
Entity typeother
Related Parties
1- filerCIK 0001657494
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 7:49 PM ET
- Size
- 22.2 KB